Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica

Journal of Rheumatology

Volumn 24, Issue 4, 1997, Pages 671-676

  Guerne, Pierre Andre ⁱ   Salvi, Marco ⁱ   Seitz, Michael ^d   Bruhlmann, Pius ^e   Rivier, Gilles ^f   Frey, Dieter ^g   Mermillod, Bernadette ^b   Vischer, Thomas L ^a   Tiercy, Jean Marie ^c,h  

^a Rheumatology Division

^b Biomathematics and Statistics Group

^c UNIVERSITY HOSPITAL   (Switzerland)

^d Inselspital   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g Felix Platter Spital   (Switzerland)

^h GENEVA UNIVERSITY HOSPITALS   (Switzerland)

ⁱ NONE

Author keywords

DR 1; HLA; Polymyalgia rheumatica; Rheumatoid arthritis; Shared epitope

Indexed keywords

HLA DR ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA;

AGED; ALLELES; ARTHRITIS, RHEUMATOID; EPITOPES; HAND; HLA-DR ANTIGENS; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMYALGIA RHEUMATICA; SYNOVITIS; TEMPORAL ARTERITIS;

EID: 0030900682     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Sakkas LI, Loqueman N, Panayi GS, Myles AB, Welsh KI: Immunogenetics of polymyalgia rheumatica. Br J Rheumatol 1990;29:331-4.
2. Weyand CM, Goronzy JJ: Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis. Curr Opin Rheumatol 1995;7:30-6.
3. Bengtsson B-A: Epidemiology of giant cell arteritis. Baillière's Clin Rheumatol 1991;5:379-85.
4. Cid MC, Ercilla G, Vilaseca J: Polymyalgia rheumatica: A syndrome associated with HLA-DR4 antigen. Arthritis Rheum 1988;31:678-82.
5. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ: The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest 1992;90:2355-61.
6. al Jarallah KF, Buchanan WW, Sastry A, Singal DP: Immunogenetics of polymyalgia rheumatica. Clin Exp Rheumatol 1993;11:529-31.
7. Weyand CM, McCarthy TG, Goronzy JJ: Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
8. Weyand CM, Hunder NN, Hicok KC, Hunder GG, Goronzy JJ: HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis. Arthritis Rheum 1994;375:514-20.
9. Healey LA: Polymyalgia rheumatica and giant cell arteritis. In: McCarty DJ, ed. Arthritis and Allied Conditions. Philadelphia, London: Lea and Febiger, 1989:1234-9.
10. Hunder GG, Bloch DA, Michel BA, et al: The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
11. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Harle JR, Pellissier JF, Desnuelle C, et al: Polymyalgia rheumatica and mitochondrial myopathy: Clinicopathologic and biochemical studies in five cases. Am J Med 1992;92:167-72.
13. Zimmermann K, Richter WO, Schwandt P: Chylomicronemia presenting as temporal arteritis (letter). Arch Intern Med 1992;152:882.
14. Lafforgue P, Senbel E, Figarella Branger D, et al: Systemic amyloidosis AL with temporal artery involvement revealing lymphoplasmacytic malignancy in a man presenting as polymyalgia rheumatica. Ann Rheum Dis 1993;52:158-60.
15. Rao JK, Allen NB: Primary systemic amyloidosis masquerading as giant cell arteritis. Case report and review of the literature. Arthritis Rheum 1993;36:422-5.
16. Fattori E, Della Rocca C, Costa P, et al: Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood 1994;83:2570-9.
17. Tiercy JM, Grundschober C, Jeannet M, Mach B: A comprehensive HLA-DRB, -DQB, and -DPB oligotyping procedure by hybridization with sequence-specific oligonucleotide probes. In: Bidwell J, Hui K, eds. Handbook for HLA tissue typing laboratories. CRC Press Inc., 1993.
18. Cros P, Allibert P, Mandrand B, Tiercy JM, Mach B: Oligonucleotide genotyping of HLA polymorphism on microtitre plates. Lancet 1992;340:870-3.
19. Zetterquist H, Olerup O: Identification of the HLA-DRB1*04, -DRB1*07, and -DRB1*09 alleles by PCR amplification with sequence-specific primers in 2 hours. Hum Immunol 1992;34:64-14.
20. Fleiss JL: Sampling methods I: Naturalistic or cross-sectional studies. In: Statistical methods for rates and proportions. Cambridge: Wyley, 1981:71-5.
21. Bird HA, Esselinckx W, Dixon ASJ, Mowat AG, Wood PHN: An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38:434-9.
22. Weyand CM, Hicok KC, Conn D, Goronzy JJ: The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992;117:801-6.
23. Gough A, Faint J, Salmon M, Bacon P, Emery P: HLA-DR4 and career prospects in rheumatology: Is there a link? BMJ 1995;311:1665-6.
24. Grundschober C, Sanchez-Mazas A, Excoffier L, Jeannet M, Tiercy JM: HLA-DPB1 DNA polymorphism in the Swiss population: Linkage disequilibrium with other HLA loci and population genetic affinities. Eur J Immunogenetics 1994;21:143-57.
25. Weyand CM, Goronzy JJ: Giant cell arteritis as an antigen-driven disease. Rheum Dis Clin North Am 1995;21:1027-39.
26. Steere AC, Dwyer E, Winchester R: Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 1990;323:219-23.
27. Hoffman RW, Sharp GC: Is anti-U1-RNP autoantibody positive connective tissue disease genetically distinct? J Rheumatol 1995;22:586-9.